Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk
therapy) for the treatment of bipolar II depression. The name of this psychotherapy is
Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will
be randomly assigned to receive either IPSRT-BPII or the medication Seroquel (quetiapine) to
manage their symptoms of bipolar II depression. Subjects will receive the assigned therapy
for up to 20 weeks.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Alliance for Research on Schizophrenia and Depression